Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism 11β-HSD1 inhibitors(Corticosteroid 11-beta-dehydrogenase isozyme 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Cognitive Dysfunction | Discovery | - | 23 Jun 2022 | |
| Depressive Disorder | Discovery | - | 23 Jun 2022 | |
| Endocrinology and Metabolic Disease | Discovery | - | 23 Jun 2022 | |
| Glaucoma | Discovery | - | 23 Jun 2022 | |
| Hypertension | Discovery | - | 23 Jun 2022 | |
| Immune System Diseases | Discovery | - | 23 Jun 2022 |





